Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

KNW

Know Labs Inc

Apr 26 • 04:00PM ET

0.6475

Dollar change +0.0325
Percentage change 5.28	%

Technology • Scientific & Technical Instruments • USA • AMEX

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.38	Insider Own	30.50%	Shs Outstand	80.36M	Perf Week	14.97%
Market Cap	53.43M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	0.00%	Shs Float	57.35M	Perf Month	1.49%
Income	-20.13M	PEG	-	EPS next Q	-0.05	Inst Own	3.66%	Short Float	0.67%	Perf Quarter	63.51%
Sales	0.00M	P/S	-	EPS this Y	53.66%	Inst Trans	130.19%	Short Ratio	2.89	Perf Half Y	162.68%
Book/sh	0.02	P/B	43.05	EPS next Y	-26.32%	ROA	-189.69%	Short Interest	0.38M	Perf Year	-28.85%
Cash/sh	0.06	P/C	11.08	EPS next 5Y	-	ROE	-362.31%	52W Range	0.23 - 1.48	Perf YTD	27.21%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-1.78%	ROI	-1642.11%	52W High	-56.25%	Beta	1.55
Dividend TTM	-	Quick Ratio	1.27	Sales past 5Y	-70.26%	Gross Margin	-	52W Low	181.52%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	1.27	EPS Y/Y TTM	13.58%	Oper. Margin	0.00%	RSI (14)	53.24	Volatility	10.64% 8.46%
Employees	11	Debt/Eq	2.33	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.00	Target Price	1.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	45.40%	Payout	-	Rel Volume	0.39	Prev Close	0.62
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	Feb 14 AMC	Avg Volume	133.31K	Price	0.65
SMA20	3.71%	SMA50	0.62%	SMA200	14.91%	Trades		Volume	52,393	Change	5.28%

Apr-05-24 09:00AM	Know Labs to Present Clinical Research at the 2024 American Physiology Summit (Business Wire)
Mar-06-24 09:00AM	Know Labs Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study (Business Wire) -9.39%
Feb-29-24 04:15PM	Know Labs Secures U.S. $12 Million Funding for Companys Further Execution on Its Clinical Research and Development Initiatives (Business Wire)
Feb-27-24 11:44AM	Know Labs Announces the KnowU, its Wearable Non-Invasive Continuous Glucose Monitor (Business Wire)
Feb-14-24 04:15PM	Know Labs, Inc. Reports First Quarter FY2024 Results (Business Wire)
09:00AM	Loading…
Feb-07-24 09:00AM	Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024 (Business Wire)
Jan-23-24 09:00AM	Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) (Business Wire)
Dec-19-23 04:15PM	Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results (Business Wire) +6.94%
Dec-14-23 09:00AM	Know Labs Expands Medical and Scientific Advisory Board (Business Wire) +10.90%
Dec-11-23 09:00AM	Know Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023 (Business Wire)
Nov-08-23 09:00AM	Know Labs Expands Board of Directors (Business Wire)
Oct-31-23 09:00AM	Know Labs Presents at Third Annual Bernstein CGM Disruptors Conference, Details Significant Progress During the Past Year (Business Wire)
Sep-27-23 08:00AM	Know Labs, Inc. Announces Pricing of $7 Million Public Offering of Common Stock (Business Wire) -32.93%
Aug-14-23 04:15PM	Know Labs, Inc. Reports Third Quarter FY2023 Results (Business Wire)
Aug-03-23 09:00AM	Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2023 Results on August 14, 2023 (Business Wire)
09:00AM	Loading…
Jul-26-23 09:00AM	Know Labs Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose Monitor (Business Wire)
Jun-07-23 08:00AM	Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring (Business Wire)
May-30-23 09:00AM	Know Labs Non-Invasive Glucose Monitoring Technology Shows Improved Accuracy (Business Wire)
May-25-23 09:29AM	Know Labs, Inc. Discusses Significant Growth of Its IP Portfolio and 2023 Goals with The Stock Day Podcast (Newsfile)
May-23-23 09:00AM	Know Labs Joins IPBC Global 2023 to Discuss the Importance of Strategic IP Development in Maximizing Shareholder Value (Business Wire)
May-18-23 09:00AM	Know Labs Furthers External Validation of Bio-RFID Technology with Study Published in Sensors Journal (Business Wire)
May-15-23 04:05PM	Know Labs, Inc. Reports Second Quarter FY2023 Results (Business Wire)
May-08-23 09:00AM	Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2023 Results on May 15, 2023 (Business Wire) +8.33%
May-05-23 09:00AM	Know Labs Study Validates Technical Feasibility of its Novel Sensor for Non-Invasive Glucose Monitoring (Business Wire) +10.20%
Apr-21-23 09:00AM	Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study (Business Wire) +7.40%
Mar-22-23 09:00AM	Know Labs Forms New Scientific Advisory Board, Appoints Respected Researchers in Medical Innovation as First Members (Business Wire)
Feb-14-23 04:00PM	Know Labs, Inc. Reports First Quarter 2023 Results (Business Wire)
Feb-07-23 09:00AM	Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2023 Results on February 14, 2023 (Business Wire)
Feb-02-23 09:00AM	Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application (Business Wire) +9.52%
Jan-27-23 09:00AM	Know Labs Announces Executive Leadership Changes and Confirms 2023 Outlook (Business Wire)
09:00AM	Loading…
Jan-26-23 09:00AM	Know Labs, Inc. Names Ron Erickson Chief Executive Officer; Former CEO Phil Bosua Becomes a Technology Consultant to the Company (Business Wire)
Jan-04-23 09:00AM	Know Labs, Inc. Expands IP Leadership in Non-Invasive Diagnostics with New High Performance Glucose Sensor Patent (Business Wire)
Dec-20-22 04:07PM	Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2022 Results (Business Wire) +22.49%
02:29PM	Know Labs, Inc. Addresses False and Incomplete Short Sellers Claims (Business Wire)
Dec-14-22 09:00AM	Know Labs, Inc. to Host Review of Fiscal Year 2022 Results on December 20, 2022 (Business Wire)
Nov-07-22 09:00AM	Know Labs Participating in Second Annual Bernstein CGM Disruptors Conference (Business Wire)
Sep-20-22 12:01PM	Know Labs, Inc. Announces Closing of $8.28 Million Public Offering of Common Stock (Business Wire) -7.21%

Know Labs, Inc. engages in the development, marketing, and sale of a photonics technology. It offers its product under the ChromaID brand. The firm operates through the following segments: The Development of Bio-RFID and ChromaID Technology, Particle, Inc. Technology, and AI Sales of NFT Products. Know Labs was founded by Ronald Peter Erickson on October 8, 1998 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
OWENS WILLIAM ARTHUR	Director	May 16 '23	Option Exercise	0.25	157,983	39,496	812,703	May 22 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KNW

Know Labs Inc

Upgrade your FINVIZ experience